Evaluation Only. Created with Aspose.PDF. Copyright 2002-2021 Aspose Pty Ltd.
8570
A. I. Khalaf et al. / Tetrahedron 56 (2000) 8567±8571
The second fraction was obtained as white solid material
(40 mg, 7%), identi®ed as 3g.9 dH (CDCl3): 2.05 (4H, t,
J8 Hz, (CH2)2CH2N); 3.66 (4H, t, J4.0 Hz, CH2N);
6.99 (1H, t, J7.8 Hz, ArH); 7.15 (1H, t, J7.8 Hz, ArH);
7.26 (1H, d, J7.8 Hz, ArH); 7.36 (1H, d, J7.8 Hz, ArH).
dC (CDCl3): 25.58, 47.40, 108.55, 115.95, 120.04, 123.81,
143.58, 149.00, 160.98. nmax: 2922, 1642, 1584, 800, 760,
(504 mg, 2.971 mmol) and N-ethylpiperidine (1.009 g,
8.913 mmol) were heated at 1308C for ®ve days. Excess
reagent was removed under reduced pressure and the
crude product was applied to a column chromatography.
Ethyl acetate/n-hexane 1/10 was used to elute the product
which was obtained as pale yellow crystalline material (3j)
(266 mg, 41% yield), Rf0.33. dH (CDCl3): 1.68 (6H, br s,
3£CH2); 3.56 (4H, br s, CH2NCH2); 7.03±7.07 (1H, dt,
J1.1 and 7.8 Hz, ArH); 7.26±7.31 (1H, dt, J1.1 and
7.8 Hz, ArH); 7.55±7.59 (2H, m, ArH). dC (CDCl3):
24.67, 25.71 (2£C), 50.02 (2£C), 119.21, 120.97, 121.44,
126.26, 131.12, 153.42, 169.25. nmax: 2945, 2924, 2846,
740 cm21
.
Reaction of N-ethylpiperidine and (1a): N-(4-chloro-
pentyl)-N-ethylaminobenzoxazole. 2-Chlorobenzoxazole
(460 mg, 3.0 mmol) and 1-ethylpiperidine (679 mg,
6.0 mmol) were dissolved in THF (20 mL, dry). The reac-
tion mixture was heated under re¯ux for 24 h. The solvent
was removed under reduced pressure and the residue puri-
®ed by column chromatography eluted with ethyl acetate/n-
hexane (1:9 v/v). The ®rst fraction was obtained as a white
solid which was identi®ed as 3i,17 (519 mg, 86%). dH
(CDCl3): 1.73 (6H, m, 3£CH2); 3.71 (4H, m, CH2N); 7.04
(1H, dt, J1.2 and 7.8 Hz, ArH); 7.19 (1H, dt, J1.2 and
7.8 Hz, ArH); 7.28 (1H, d, J7.8 Hz, ArH); 7.39 (1H, d,
J7.8 Hz, ArH). dC (CDCl3): 24.08, 25.24 (2£C); 46.62
(2£C); 108.54, 116.00, 120.26, 123.82, 143.39, 148.71,
162.47. nmax: 2941, 2854, 1643, 1576, 1454, 1275, 792,
754, 743 cm21. A second fraction (compound of type 4,
N-(4-chloropentyl)-N-ethylaminobenzoxazole) was obtained
as a colourless oil (55 mg, 7%). dH (CDCl3): 1.27±1.31 (3H,
t, J7.1 Hz, CH2CH3), 1.49±1.58 (2H, m, CH2), 1.69±1.77
(2H, m, CH2), 1.82±1.89 (2H, qt, J6.7 Hz, CH2), 3.51 (2H,
t, J7.4 Hz, CH2N), 3.53 (2H, t, J6.7 Hz, CH2Cl), 3.57
(2H, q, J7.3 Hz, NCH2CH3), 6.99 (1H, dt, J1.2 and
7.8 Hz, ArH), 7.15 (1H, dt, J1.2 and 7.8 Hz, ArH), 7.27
(1H, d, J7.8 Hz, ArH), 7.34 (1H, d, J7.8 Hz, ArH). dC
(CDCl3): 13.29, 24.09, 27.54, 32.30, 43.47, 44.80, 48.01,
1593, 1561, 1535, 1444, 1261, 762, 732 cm21
.
2-N-methyl-N-phenylaminobenzothiazole (3k).18 The
same procedure for the synthesis of (3f) was employed to
give the product as a colourless oil. dH (CDCl3): 3.66 (3H, s,
NMe); 7.09 (1H, dt, J1.1 and 7.8 Hz, ArH); 7.30±7.52
(7H, m, ArH); 7.66 (1H, d, J7.8 Hz, ArH). dC (CDCl3):
40.59, 119.36, 120.60, 121.88, 126.00, 126.12 (2£C),
127.55, 130.06 (2£C), 131.33, 145.96, 152.78, 168.37.
n
max: 3063, 1593, 1521, 755 cm21
.
1-Methyl-1H,2H,3H,4H,5H-[1,3]diazepino[2,1-b][1,3]benz-
oxazol-6-ium iodide (compound of type 5). N-(4-chloro-
butyl)-N-methylaminobenzoxazole (20 mg, 0.084 mmol)
was dissolved in dry acetone (5 mL) to which was added
anhydrous sodium iodide (25 mg, 0.10 mmol). The solution
was heated under re¯ux for 8 h and allowed to cool to room
temperature. The sodium chloride precipitate was ®ltered
and the solvent evaporated to dryness under reduced pres-
sure, to afford the product as a white solid (25 mg, 90%).
mp.2408C. dH (CDCl3): 2.27±2.39 (4H, m, 2£CH2), 3.50
(3H, s, NMe), 4.02 (2H, t, J5.6 Hz, NCH2), 4.48 (2H, t,
J5.6 Hz, N1CH2), 7.31±7.36 (1H, m, ArH), 7.39±7.47
(3H, m, ArH). dC (CDCl3): 24.60, 24.42 (CH2±CH2),
41.97 (NMe), 47.14 (NCH2), 54.48 (N1CH2), 111.46,
111.91, 125.54, 126.67 (CH of Ar), 131.92, 144.35 (C of
Ar), 158.6 (N1vC±O(N)). HRFABMS Found 203.11834
(95%, base peak), calculated for C12H15N2O 203.11844
108.53, 115.89, 120.04, 123.83, 148.82, 162.47. nmax
:
2939, 1649, 1585, 1462, 760, 745 cm21. HREIMS: found
266.119, calculated for C14H19N2O35Cl 266.119; and found
268.116, calculated for C14H19N2O37Cl 268.116.
Reaction of (1b) with N-methylpyrrolidine: formation of
N-(4-chlorobutyl)-N-methylaminobenzothiazole.
The
(M12I2). nmax 1685, 1480, 1400, 1267, 1164, 758 cm21
.
same experimental procedure as above was employed to
give two products eluted with ethyl acetate/petroleum
ether (1:3 v/v). The ®rst fraction (compound of type 4,
N-(4-chlorobutyl)-N-methylaminobenzothiazole) was obtained
as a colourless oil (83%). dH (CDCl3): 1.82±1.85 (4H, m,
2£CH2), 3.18 (3H, s, NMe), 3.56±3.59 (4H, m, NCH2 and
CH2Cl), 7.06 (1H, dt, J1.2 and 7.8 Hz, ArH), 7.29 (1H, dt,
J1.2 and 7.8 Hz, ArH), 7.55 (1H, d, J7.8 Hz, ArH), 7.59
(1H, d, J7.8 Hz, ArH). dC (CDCl3): 24.84, 29.84, 38.14,
44.78, 52.47, 118.97, 120.77, 121.14, 126.13, 131.04,
153.37, 168.50. nmax: 2956, 2867, 1598, 1544, 1447, 1293,
754, 727 cm21. HREIMS: found 254.065 calculated for
C12H15N2S35Cl 254.064; and found 256.063 calculated for
C12H15N2S37Cl 256.063. The second fraction (3h) was
obtained as a white solid (7%).16 dH (CDCl3): 2.05 (4H, t,
J8.0 Hz, 2£CH2); 3.66 (4H, t, J4.0 Hz, 2£NCH2); 7.03±
7.06 (1H, dt, J1.1 and 7.8 Hz, ArH); 7.27±7.31 (1H, dt,
J1.1 and 7.8 Hz, ArH); 7.57±7.61 (2H, m, ArH). dC
(CDCl3): 25.88, 49.71, 118.91, 120.88, 126.12, 131.96,
Acknowledgements
The authors would like to acknowledge the grant gratefully
received by R. G. A. from the D.G.U.I. (Gobierno de
Canarias).
References
1. (a) Khalaf, A. I.; Pitt, A. R.; Scobie, M.; Suckling, C. J.; Urwin,
J.; Waigh, R. D.; Young, S. C.; Fishleigh, R. V.; Fox, K. R. J. Med.
Chem. in press. (b) Khalaf, A. I.; Pitt, A. R.; Scobie, M.; Suckling,
C. J.; Urwin, J.; Waigh, R. D.; Young, S. C.; Fishleigh, R. V.
Tetrahedron 2000, 56, 5225±5239. (c) Khalaf, A. I.; Pitt, A. R.;
Scobie, M.; Suckling, C. J.; Urwin, J.; Waigh, R. D.; Young, S. C.;
Fishleigh, R. V. J. Chem. Res., Synopsis 2000, 246±265; J. Chem.
Res., Miniprint 0751±0770.
153.55, 165.58. nmax: 2922, 1642, 1583, 1459, 761 cm21
.
2. Brown, H. C. J. Am. Chem. Soc. 1945, 67, 378±380.
3. (a) Miller, J. Aromatic Nucleophilic Substitution; Elsevier:
Amsterdam, 1968. (b) Bacaloglu, R.; Blasko, A.; Bunton, C. A.;
2-Piperidinobenzothiazole (3j). 2-Chlorobenzothiazole